Arrowhead Research | ARWR - Capitale Di Prestito





Capitale Di Prestito Cambiamento Data
Agios Pharmaceuticals USD 1.06M 0 2022-09
Alnylam Pharmaceuticals USD 2.47B 6.56M 2026-06
Arrowhead Research USD 824.07M 401.34M 2026-06
Heron Therapeutics USD 140.64M 975K 2025-12
Incyte USD 28.42M 994K 2026-06
Ionis Pharmaceuticals USD 1.91B 6.62M 2026-06
Ligand Pharmaceuticals USD 446.9M 704K 2026-03
Merck USD 51.08B 4.41B 2026-06
Moderna USD 597M 6M 2026-06
Nektar Therapeutics USD 60.27M 2.89M 2026-03
Novartis USD 37.49B 42M 2026-06
Sarepta Therapeutics USD 847.62M 9.46M 2026-06
TG Therapeutics USD 745.39M 247K 2026-06
Ultragenyx Pharmaceutical USD 1.13B 19M 2026-03
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12
Xencor USD 77.54M 4.59M 2026-06